75 - High Rates of Virologic Suppression with DTG/3TC in Newly Diagnosed Adults with HIV-1 Infection and Baseline Viral Load >500,000 c/mL: 48-Week Subgroup Analysis of the STAT Study

On Demand

Participants should be aware of the following financial/non-financial relationships:

Charlotte-Paige M. Rolle, MD MPH: Gilead Sciences (Grant/Research Support, Scientific Research Study Investigator, Speaker's Bureau)Janssen Infectious Disease (Scientific Research Study Investigator, Advisor or Review Panel member)ViiV Healthcare (Grant/Research Support, Scientific Research Study Investigator, Advisor or Review Panel member, Speaker's Bureau)

Mezgebe Berhe, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Tulika Singh, MD MS AAHIVS: Gilead (Grant/Research Support, Advisor or Review Panel member)ViiV (Grant/Research Support, Advisor or Review Panel member, Speaker's Bureau)

Roberto Ortiz, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Anson K. Wurapa, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Moti Ramgopal, MD FIDSA: Abbvie (Scientific Research Study Investigator, Speaker's Bureau)Gilead (Consultant, Scientific Research Study Investigator, Speaker's Bureau)Janssen (Consultant, Scientific Research Study Investigator, Research Grant or Support, Speaker's Bureau)Merck (Consultant, Scientific Research Study Investigator)ViiV (Consultant, Scientific Research Study Investigator, Speaker's Bureau)

Dushyantha Jayaweera, MD, mrcog(uk), face: Gilead (Research Grant or Support)Janssen (Research Grant or Support)viiv (Research Grant or Support)

Peter Leone, MD: viiv healthcare (Employee)

Jessica Matthews, BS: ViiV Healthcare (Employee)

Michael Cupo, Ph.D.: GlaxoSmithKline (Employee)

Mark Underwood, PhD: GlaxoSmithKline (Shareholder)ViiV Healthcare (Employee)

Kostas Angelis, PhD: GSK (Employee, Shareholder)

Brian Wynne, MD: ViiV Healthcare (Employee, Shareholder, I have shares in GSK, the part owner of ViiV)

Deanna Merrill, PharmD, MBA, AAHIVP: GlaxoSmithKline (Shareholder)ViiV Healthcare (Employee)

Christopher T. Nguyen, MD: ViiV Healthcare (Employee)

Jean A. van Wyk, MB,ChB: GlaxoSmithKline (Shareholder)ViiV Healthcare (Employee)

Andrew Zolopa, MD: GlaxoSmithKline (Shareholder)ViiV Healthcare (Employee)

Presenting Author(s)

Charlotte-Paige M. Rolle, MD MPH

Director of Research Operations
Orlando Immunology Center
Orlando, FL, United States

Gilead Sciences (Grant/Research Support, Scientific Research Study Investigator, Speaker's Bureau)Janssen Infectious Disease (Scientific Research Study Investigator, Advisor or Review Panel member)ViiV Healthcare (Grant/Research Support, Scientific Research Study Investigator, Advisor or Review Panel member, Speaker's Bureau)

Slides Slides and Audio

Co-Author(s)

MB

Mezgebe Berhe, MD

Infectious Disease specialist
North Texas Infectious Diseases Consultants
Dallas, TX, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.
TS

Tulika Singh, MD MS AAHIVS

Clinical Assistant Professor
University of California, Riverside
Palm Springs, CA, United States

Gilead (Grant/Research Support, Advisor or Review Panel member)ViiV (Grant/Research Support, Advisor or Review Panel member, Speaker's Bureau)
RO

Roberto Ortiz, MD

Bliss Healthcare Services
Orlando, Florida, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.
AW

Anson K. Wurapa, MD

Infectios Disease Specialist
Infectious Disease Specialists of Atlanta
Atlanta, GA, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.
MR

Moti Ramgopal, MD FIDSA

Chief Medical Officer
Midway Specialty Care Centers
Fort Pierce, Florida, United States

Abbvie (Scientific Research Study Investigator, Speaker's Bureau)Gilead (Consultant, Scientific Research Study Investigator, Speaker's Bureau)Janssen (Consultant, Scientific Research Study Investigator, Research Grant or Support, Speaker's Bureau)Merck (Consultant, Scientific Research Study Investigator)ViiV (Consultant, Scientific Research Study Investigator, Speaker's Bureau)
DJ

Dushyantha Jayaweera, MD, mrcog(uk), face

Professor
University of Miami
Miami, Florida, United States

Gilead (Research Grant or Support)Janssen (Research Grant or Support)viiv (Research Grant or Support)
PL

Peter Leone, MD

physician project lead
ViiV Healthcare
Chapel hill, North Carolina, United States

viiv healthcare (Employee)
JM

Jessica Matthews, BS

Clinical Development Director
ViiV Healthcare
RTP, NC, United States

ViiV Healthcare (Employee)
MC

Michael Cupo, Ph.D.

Manager, Clinical Development
GlaxoSmithKline
Collegeville, PA, United States

GlaxoSmithKline (Employee)
MU

Mark Underwood, PhD

Clinical Development Investigator, Clinical Virology
ViiV Healthcare
Durham, NC, United States

GlaxoSmithKline (Shareholder)ViiV Healthcare (Employee)
KA

Kostas Angelis, PhD

Biostatistician
GSK
London, England, United Kingdom

GSK (Employee, Shareholder)
BW

Brian Wynne, MD

Director
ViiV Healthcare
Durham, NC, United States

ViiV Healthcare (Employee, Shareholder, I have shares in GSK, the part owner of ViiV)
DM

Deanna Merrill, PharmD, MBA, AAHIVP

ViiV Healthcare
Research Triangle Park, North Carolina, United States

GlaxoSmithKline (Shareholder)ViiV Healthcare (Employee)
CN

Christopher T. Nguyen, MD

Regional Medical Director
ViiV Healthcare
RTP, North Carolina, United States

ViiV Healthcare (Employee)
Jv

Jean A. van Wyk, MB,ChB

Medical Director
ViiV Healthcare
Brentford, England, United Kingdom

GlaxoSmithKline (Shareholder)ViiV Healthcare (Employee)
AZ

Andrew Zolopa, MD

Global Medical Director
ViiV Healthcare
Research Triangle Park, North Carolina, United States

GlaxoSmithKline (Shareholder)ViiV Healthcare (Employee)